Interferon-inducible effector mechanisms in cell-autonomous immunity. - Test2 - elhamkhani - TriplyDB

Interferon-inducible effector mechanisms in cell-autonomous immunity.

Interferon-inducible effector mechanisms in cell-autonomous immunity.

http://www.wikidata.org/entity/Q34114819

about

Zika Virus Targets Human STAT2 to Inhibit Type I Interferon Signaling Targeting Innate Immunity for Antiviral Therapy through Small Molecule Agonists of the RLR Pathway Dengue virus infection induces interferon-lambda1 to facilitate cell migration Viral Inhibition of the IFN-Induced JAK/STAT Signalling Pathway: Development of Live Attenuated Vaccines by Mutation of Viral-Encoded IFN-Antagonists Phleboviruses and the Type I Interferon Response Post-Transcriptional Control of LINE-1 Retrotransposition by Cellular Host Factors in Somatic Cells The cytoskeleton in cell-autonomous immunity: structural determinants of host defence Regulation of type I interferon responses Cellular self-defense: how cell-autonomous immunity protects against pathogens Type I interferon response and innate immune sensing of cancer IFNs Modify the Proteome of Legionella-Containing Vacuoles and Restrict Infection Via IRG1-Derived Itaconic Acid Identification of the microsporidian Encephalitozoon cuniculi as a new target of the IFNγ-inducible IRG resistance system Genome of Acanthamoeba castellanii highlights extensive lateral gene transfer and early evolution of tyrosine kinase signaling The many faces of the flavivirus NS5 protein in antagonism of type I interferon signaling Pathophysiological role of guanylate-binding proteins in gastrointestinal diseases Bacterial recognition pathways that lead to inflammasome activation Long-Term Relationships: the Complicated Interplay between the Host and the Developmental Stages of Toxoplasma gondii during Acute and Chronic Infections Disease-promoting effects of type I interferons in viral, bacterial, and coinfections Inhibition of pyrimidine biosynthesis pathway suppresses viral growth through innate immunity Evolution of Cell-Autonomous Effector Mechanisms in Macrophages versus Non-Immune Cells Interferon-induced guanylate-binding proteins in inflammasome activation and host defense Maternal-Fetal Transmission of Zika Virus: Routes and Signals for Infection Virus/Allergen Interaction in Asthma Exacerbation Tetherin Sensitivity of Influenza A Viruses Is Strain Specific: Role of Hemagglutinin and Neuraminidase.Collective nitric oxide production provides tissue-wide immunity during Leishmania infection.The bacterial pathogen Listeria monocytogenes and the interferon family: type I, type II and type III interferons In vivo and in vitro studies suggest a possible involvement of HPV infection in the early stage of breast carcinogenesis via APOBEC3B induction.Mycobacterium tuberculosis EsxH inhibits ESCRT-dependent CD4+ T-cell activation The Toxoplasma pseudokinase ROP5 forms complexes with ROP18 and ROP17 kinases that synergize to control acute virulence in mice.Enteropathogenic Escherichia coli inhibits type I interferon- and RNase L-mediated host defense to disrupt intestinal epithelial cell barrier function Modulation of innate immunity by Toxoplasma gondii virulence effectors.The interferon-induced gene Ifi27l2a is active in lung macrophages and lymphocytes after influenza A infection but deletion of Ifi27l2a in mice does not increase susceptibility to infection.Cell-autonomous effector mechanisms against mycobacterium tuberculosis.Use of transgenic parasites and host reporters to dissect events that promote interleukin-12 production during toxoplasmosis The human adenovirus type 5 E1B 55 kDa protein obstructs inhibition of viral replication by type I interferon in normal human cells.Guanylate binding proteins promote caspase-11-dependent pyroptosis in response to cytoplasmic LPS.Caspase-11 activation requires lysis of pathogen-containing vacuoles by IFN-induced GTPases.Reverse interferon signature is characteristic of antigen-presenting cells in human and rat spondyloarthritis.Protective immunity against Toxoplasma gondii induced by DNA immunization with the gene encoding a novel vaccine candidate: calcium-dependent protein kinase 3 A dual character of flavonoids in influenza A virus replication and spread through modulating cell-autonomous immunity by MAPK signaling pathways.

P2860

Q24261402-193DD544-A5C9-4D90-8510-9DA4AC0F5558 Q26700090-27568A24-46E2-44E3-8A5F-547816CC6F70 Q26700107-F7B080F3-1CBA-4DEA-9A3D-8EBC9E6F5020 Q26745547-4B6AC241-C0C3-49E2-9DA7-B95DF4FF0ACF Q26747457-D6EB3E49-CC26-428A-8D17-E556FFA658EE Q26750825-C8AAD004-9311-49CC-AC9C-D4514FE4E8FF Q26796274-BCF0C8F2-5A73-43BA-AFA0-620C8D6FC89D Q26853177-64EDACAA-5C59-4519-93EA-90E9B037A553 Q26864521-EEA372AA-E716-454E-A7DE-80102FEA056C Q27023235-02340135-3E93-4578-9C8E-365068608593 Q27316130-FE545928-F41D-4CEE-A6FA-0466637AFD5F Q27323191-174C80B0-BA40-4C8C-B815-BDB0AE52B481 Q27499704-5F88E0A4-2DB3-48D3-A19F-BB97FAF2E7F5 Q27924714-26965DF4-9072-4BB9-ABFC-851060A4E247 Q28078361-2872603A-78FA-43EA-A707-55660AA421B9 Q28081450-48EBFBB8-E52E-45A3-A12F-A6B5B48959E7 Q28082315-C9CD2863-AE24-4E52-A1E3-B76C9D4BA024 Q28082841-B44DD38F-C6D9-41E3-A737-73DA2FE72C95 Q28534057-4813DED2-8F15-49E9-9D36-884E4DB7C8EE Q28559840-BAF37F88-8646-463D-8167-D1E726A079CE Q28595838-D7CE95FB-9249-4DBF-9162-342037672806 Q29451356-6ABB14B5-99BE-46F4-AB5B-0517C15AF0A9 Q30355433-231D7B94-07BE-44B3-AD13-C13338997BDD Q30376050-B10F6B17-A8E3-44F1-94D1-D629ECE5E6AF Q30575293-FB21A78C-340A-4459-9073-CE2C40D77739 Q33563711-629A3AA8-FCD5-4873-99C6-408C4E51A833 Q33654853-32C6A27C-D459-43C0-A22F-A0F084CA9BC3 Q33751370-F30D178F-68C8-4C60-8003-5B649AC838B8 Q33861156-72F195A8-7076-4196-8E21-0ACC3A184A9D Q33899677-4A6DA5E9-122D-4BDC-AEE8-1D9AD4E8EEF7 Q34033981-D0ECCEF3-2725-41DF-9FE9-85985D7C2842 Q34128745-7A853F03-3561-47E5-954A-F981296A2F9A Q34287676-D97B1EBE-5765-4ADB-B32D-86C9B30AF416 Q34298654-53BD61BF-FB0A-469C-9F98-75A12B5BFCA7 Q34388476-415C6C59-566C-423E-B733-634C4C008C27 Q34414371-5C84E017-DD48-4595-9563-7DC9502B31FC Q34415551-D5240161-19C9-4AE2-95F6-EDDFE69CBA24 Q34481463-7941C059-6519-4447-B6C0-05A097099936 Q34494113-B4DB3B8D-494E-4D0D-B7B1-AFF65B410F47 Q34581402-131CD6AC-CDCF-49CC-8786-9D4A9F1F075C

P2860

Interferon-inducible effector mechanisms in cell-autonomous immunity.

http://www.wikidata.org/entity/Q34114819

description

2012 nî lūn-bûn

@nan

2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Interferon-inducible effector mechanisms in cell-autonomous immunity.

@ast

Interferon-inducible effector mechanisms in cell-autonomous immunity.

@en

Interferon-inducible effector mechanisms in cell-autonomous immunity.

@nl

type

label

Interferon-inducible effector mechanisms in cell-autonomous immunity.

@ast

Interferon-inducible effector mechanisms in cell-autonomous immunity.

@en

Interferon-inducible effector mechanisms in cell-autonomous immunity.

@nl

prefLabel

Interferon-inducible effector mechanisms in cell-autonomous immunity.

@ast

Interferon-inducible effector mechanisms in cell-autonomous immunity.

@en

Interferon-inducible effector mechanisms in cell-autonomous immunity.

@nl

P1433

Q34114819-3F021C18-3FD3-440A-913C-3C69E8025E41

P1476

Q34114819-2F013AAA-A1D5-4914-83D2-667D7CB6489D

P2093

Q34114819-7BD171F1-0C73-409F-BACF-E553AD7CB795

P2860

Q34114819-09345A0A-9C96-4F63-AA2A-D0653771EE02

Q34114819-0B486735-7428-4017-B115-FF11EAFCB403

Q34114819-0C5FF1CA-FB63-4A1C-BB08-349E5DE8F772

Q34114819-0D2D0C19-412B-45CD-959A-42EB1527D4CC

Q34114819-0E00BCF6-BB9D-481D-AD2B-4E95BC97F53D

Q34114819-0EE98BC3-1FEF-4404-816C-D9ED020D2211

Q34114819-0FA6FD81-AD59-441D-9B85-1017A6BC99D0

Q34114819-1075DA64-4E53-4590-BE2D-9F17EE63173C

Q34114819-181C882B-CF08-42F8-9F98-06E66D25D791

Q34114819-18327C9F-D2F7-422A-9BC7-25167E7D5833

P304

Q34114819-D4BF1A49-AE4E-4B49-84FD-2B7F9D22A8CB

P31

Q34114819-E6BBB777-01BE-4EF6-9094-65BAC3100AB4

P356

Q34114819-4129D6BD-8963-4925-B216-79A7294D072D

P433

Q34114819-4CA7A0D8-5E91-4C4C-BC74-CE25E4C9E276

P478

Q34114819-C2D843F1-26B1-43CF-BF4E-ABE82F359CD6

P577

Q34114819-F183F068-4B29-414C-B343-1C642AE69F48

P698

Q34114819-A4729736-5723-46BF-80AD-9ECB687416B3

P932

Q34114819-8D02FB8E-57A4-414A-8B65-8B7C8C3026A7

P356

P1433

Nature Reviews Immunology

P1476

Interferon-inducible effector mechanisms in cell-autonomous immunity.

@en

P2093

John D MacMicking

http://www.w3.org/2001/XMLSchema#string

P2860

IFITM3 inhibits influenza A virus infection by preventing cytosolic entry

Autophagy gene variant IRGM -261T contributes to protection from tuberculosis caused by Mycobacterium tuberculosis but not by M. africanum strains

IFN-gamma-inducible Irga6 mediates host resistance against Chlamydia trachomatis via autophagy

Disruption of Toxoplasma gondii parasitophorous vacuoles by the mouse p47-resistance GTPases.

Image-based genome-wide siRNA screen identifies selective autophagy factors

TRIM5 is an innate immune sensor for the retrovirus capsid lattice

Galectin 8 targets damaged vesicles for autophagy to defend cells against bacterial invasion

Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms

Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth

Structural basis of HIV-1 tethering to membranes by the BST-2/tetherin ectodomain

P304

367-382

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRI3210

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22531325

http://www.w3.org/2001/XMLSchema#string

P932

4150610

http://www.w3.org/2001/XMLSchema#string